IndraLab

Statements

USP37 activates resistance breast cancer cells adriamycin. 1 / 1

| 1

eidos

"Conclusion : Knockdown of USP37 gene expression can reverse the resistance of breast cancer cells to adriamycin , and down-regulating USP37 might be a valuable strategy against ADR resistance in breast cancer therapy ."

33390801

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP37 activates resistance breast cancer cells adriamycin. 1 / 1

INDRA sources:

Databases

Reading